Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?The Motley Fool • 07/01/24
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes AssociationPRNewsWire • 06/24/24
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall StreetThe Motley Fool • 06/17/24
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor EnthusiasmInvestorPlace • 06/08/24
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease DrugInvestors Business Daily • 06/04/24